Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 276 entries
Sorted by: Best Match Show Resources per page
Sox3 Is Required for Gonadal Function, but Not Sex Determination, in Males and Females

STEM and males

Meeks JJ, Raverot G.
GSID: x-bGRcxqnxQJ
J Weiss, JJ Meeks, L Hurley, G Raverot… - … and Cellular Biology, 2003 - Am Soc Microbiol

… The targeting vector was electroporated into R1 embryonic stem (… Males were housed with pairs of female mice for 14 to 20 … For sperm collection, proven breeder males were sacrificed, …

Cite
Weiss, J., Meeks, J. J., Hurley, L., Raverot, G., Frassetto, A., & Jameson, J. L. (2003). Sox3 is required for gonadal function, but not sex determination, in males and females. Molecular and Cellular Biology, 23(22), 8084-8091.
Weiss, Jeffrey, et al. "Sox3 is required for gonadal function, but not sex determination, in males and females." Molecular and Cellular Biology 23.22 (2003): 8084-8091.
Copy Download .nbib Format: MLA
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

interventions

Altman DG, Deeks JJ, Song F.
GSID: DP63FMqMs68J
F Song, DG Altman, AM Glenny, JJ Deeks - Bmj, 2003 - bmj.com

Objective: To determine the validity of adjusted indirect comparisons by using data from published meta-analyses of randomised trials. Design: Direct comparison of different …

Raising the Bar: Further Improvement is Required to Make More Test Accuracy Research Fit for Decision-making.

Clinical chemistry

Deeks JJ.
PMID: 28606914
Clin Chem. 2017 Aug;63(8):1315-1317. doi: 10.1373/clinchem.2017.274431. Epub 2017 Jun 12.

No abstract available.

Cite
Deeks JJ. Raising the Bar: Further Improvement is Required to Make More Test Accuracy Research Fit for Decision-making. Clin Chem. 2017;63(8):1315-1317doi: 10.1373/clinchem.2017.274431.
Deeks, J. J. (2017). Raising the Bar: Further Improvement is Required to Make More Test Accuracy Research Fit for Decision-making. Clinical chemistry, 63(8), 1315-1317. https://doi.org/10.1373/clinchem.2017.274431
Deeks, Jonathan J. "Raising the Bar: Further Improvement is Required to Make More Test Accuracy Research Fit for Decision-making." Clinical chemistry vol. 63,8 (2017): 1315-1317. doi: https://doi.org/10.1373/clinchem.2017.274431
Deeks JJ. Raising the Bar: Further Improvement is Required to Make More Test Accuracy Research Fit for Decision-making. Clin Chem. 2017 Aug;63(8):1315-1317. doi: 10.1373/clinchem.2017.274431. Epub 2017 Jun 12. PMID: 28606914.
Copy Download .nbib Format: NLM
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.

PLoS pathogens

Serrano-Villar S, Sainz T, Ma ZM, Utay NS, Chun TW, Mann S, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Deeks SG, Landay A, Pollard RB, Miller CJ, Moreno S, Asmuth DM.
PMID: 27015639
PLoS Pathog. 2016 Mar 25;12(3):e1005540. doi: 10.1371/journal.ppat.1005540. eCollection 2016 Mar.

No abstract available.

Cite
Serrano-Villar S, Sainz T, Ma ZM, et al. Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS Pathog. 2016;12(3):e1005540doi: 10.1371/journal.ppat.1005540.
Serrano-Villar, S., Sainz, T., Ma, Z. M., Utay, N. S., Chun, T. W., Mann, S., Kashuba, A. D., Siewe, B., Albanese, A., Troia-Cancio, P., Sinclair, E., Somasunderam, A., Yotter, T., Deeks, S. G., Landay, A., Pollard, R. B., Miller, C. J., Moreno, S., & Asmuth, D. M. (2016). Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS pathogens, 12(3), e1005540. https://doi.org/10.1371/journal.ppat.1005540
Serrano-Villar, Sergio, et al. "Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial." PLoS pathogens vol. 12,3 (2016): e1005540. doi: https://doi.org/10.1371/journal.ppat.1005540
Serrano-Villar S, Sainz T, Ma ZM, Utay NS, Chun TW, Mann S, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Deeks SG, Landay A, Pollard RB, Miller CJ, Moreno S, Asmuth DM. Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS Pathog. 2016 Mar 25;12(3):e1005540. doi: 10.1371/journal.ppat.1005540. eCollection 2016 Mar. PMID: 27015639; PMCID: PMC4807777.
Copy Download .nbib Format: NLM
A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals.

Pathogens & immunity

Cockerham LR, Yukl SA, Harvill K, Somsouk M, Joshi SK, Sinclair E, Liegler T, Hoh R, Lyons S, Hunt PW, Rupert A, Sereti I, Morcock DR, Rhodes A, Emson C, Hellerstein MK, Estes JD, Lewin S, Deeks SG, Hatano H.
PMID: 28936485
Pathog Immun. 2017;2(3):310-334. doi: 10.20411/pai.v2i3.207. Epub 2017 Aug 02.

BACKGROUND: In HIV infection, lymphoid tissue is disrupted by fibrosis. Angiotensin converting enzyme inhibitors have anti-fibrotic properties. We completed a pilot study to assess whether the addition of lisinopril to antiretroviral therapy (ART) reverses fibrosis of gut tissue, and...

Cite
Cockerham LR, Yukl SA, Harvill K, et al. A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals. Pathog Immun. 2017;2(3):310-334doi: 10.20411/pai.v2i3.207.
Cockerham, L. R., Yukl, S. A., Harvill, K., Somsouk, M., Joshi, S. K., Sinclair, E., Liegler, T., Hoh, R., Lyons, S., Hunt, P. W., Rupert, A., Sereti, I., Morcock, D. R., Rhodes, A., Emson, C., Hellerstein, M. K., Estes, J. D., Lewin, S., Deeks, S. G., & Hatano, H. (2017). A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals. Pathogens & immunity, 2(3), 310-334. https://doi.org/10.20411/pai.v2i3.207
Cockerham, Leslie R, et al. "A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals." Pathogens & immunity vol. 2,3 (2017): 310-334. doi: https://doi.org/10.20411/pai.v2i3.207
Cockerham LR, Yukl SA, Harvill K, Somsouk M, Joshi SK, Sinclair E, Liegler T, Hoh R, Lyons S, Hunt PW, Rupert A, Sereti I, Morcock DR, Rhodes A, Emson C, Hellerstein MK, Estes JD, Lewin S, Deeks SG, Hatano H. A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals. Pathog Immun. 2017;2(3):310-334. doi: 10.20411/pai.v2i3.207. Epub 2017 Aug 02. PMID: 28936485; PMCID: PMC5604865.
Copy Download .nbib Format: NLM
Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions.

Research synthesis methods

Higgins JP, Ramsay C, Reeves BC, Deeks JJ, Shea B, Valentine JC, Tugwell P, Wells G.
PMID: 26053536
Res Synth Methods. 2013 Mar;4(1):12-25. doi: 10.1002/jrsm.1056. Epub 2012 Sep 25.

Non-randomized studies may provide valuable evidence on the effects of interventions. They are the main source of evidence on the intended effects of some types of interventions and often provide the only evidence about the effects of interventions on...

Cite
Higgins JP, Ramsay C, Reeves BC, et al. Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions. Res Synth Methods. 2012;4(1):12-25doi: 10.1002/jrsm.1056.
Higgins, J. P., Ramsay, C., Reeves, B. C., Deeks, J. J., Shea, B., Valentine, J. C., Tugwell, P., & Wells, G. (2013). Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions. Research synthesis methods, 4(1), 12-25. https://doi.org/10.1002/jrsm.1056
Higgins, Julian Pt, et al. "Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions." Research synthesis methods vol. 4,1 (2013): 12-25. doi: https://doi.org/10.1002/jrsm.1056
Higgins JP, Ramsay C, Reeves BC, Deeks JJ, Shea B, Valentine JC, Tugwell P, Wells G. Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions. Res Synth Methods. 2013 Mar;4(1):12-25. doi: 10.1002/jrsm.1056. Epub 2012 Sep 25. PMID: 26053536.
Copy Download .nbib Format: NLM
Spatial and temporal regulation of the pesticide dieldrin within industrial catchments.

The Science of the total environment

Mehar AA, Wright J, Leeks GJ, Wass P, Osborn D.
PMID: 10847166
Sci Total Environ. 2000 May 05;251:255-63. doi: 10.1016/s0048-9697(00)00388-0.

The river catchments of south Yorkshire support a very high density of wool processing industries. Dieldrin was once used as a moth proofing agent, as a sheep dip, and as a pesticide to protect wool fleeces during storage and...

Cite
Mehar AA, Wright J, Leeks GJ, et al. Spatial and temporal regulation of the pesticide dieldrin within industrial catchments. Sci Total Environ. 2000;251:255-63doi: 10.1016/s0048-9697(00)00388-0.
Mehar, A. A., Wright, J., Leeks, G. J., Wass, P., & Osborn, D. (2000). Spatial and temporal regulation of the pesticide dieldrin within industrial catchments. The Science of the total environment, 251255-63. https://doi.org/10.1016/s0048-9697(00)00388-0
Mehar, et al. "Spatial and temporal regulation of the pesticide dieldrin within industrial catchments." The Science of the total environment vol. 251 (2000): 255-63. doi: https://doi.org/10.1016/s0048-9697(00)00388-0
Mehar AA, Wright J, Leeks GJ, Wass P, Osborn D. Spatial and temporal regulation of the pesticide dieldrin within industrial catchments. Sci Total Environ. 2000 May 05;251:255-63. doi: 10.1016/s0048-9697(00)00388-0. PMID: 10847166.
Copy Download .nbib Format: NLM
Initial Organic Products of Fixation of [N]Dinitrogen by Root Nodules of Soybean (Glycine max).

Plant physiology

Meeks JC, Wolk CP, Schilling N, Shaffer PW.
PMID: 16660438
Plant Physiol. 1978 Jun;61(6):980-3. doi: 10.1104/pp.61.6.980.

When detached soybean Glycine max (L.) Merr. cv. Hark, nodules assimilate [(13)N]N(2), the initial organic product of fixation is glutamine; glutamate becomes more highly radioactive than glutamine within 1 minute; (13)N in alanine becoms detectable at 1 minute of...

Cite
Meeks JC, Wolk CP, Schilling N, et al. Initial Organic Products of Fixation of [N]Dinitrogen by Root Nodules of Soybean (Glycine max). Plant Physiol. 1978;61(6):980-3doi: 10.1104/pp.61.6.980.
Meeks, J. C., Wolk, C. P., Schilling, N., & Shaffer, P. W. (1978). Initial Organic Products of Fixation of [N]Dinitrogen by Root Nodules of Soybean (Glycine max). Plant physiology, 61(6), 980-3. https://doi.org/10.1104/pp.61.6.980
Meeks, J C, et al. "Initial Organic Products of Fixation of [N]Dinitrogen by Root Nodules of Soybean (Glycine max)." Plant physiology vol. 61,6 (1978): 980-3. doi: https://doi.org/10.1104/pp.61.6.980
Meeks JC, Wolk CP, Schilling N, Shaffer PW. Initial Organic Products of Fixation of [N]Dinitrogen by Root Nodules of Soybean (Glycine max). Plant Physiol. 1978 Jun;61(6):980-3. doi: 10.1104/pp.61.6.980. PMID: 16660438; PMCID: PMC1092024.
Copy Download .nbib Format: NLM
Two-way Bayesian hierarchical phylogenetic models: An application to the co-evolution of gp120 and gp41 during and after enfuvirtide treatment.

Computational statistics & data analysis

Kitchen CM, Kroll J, Kuritzkes DR, Bloomquist E, Deeks SG, Suchard MA.
PMID: 20442796
Comput Stat Data Anal. 2009 Jan 15;53(3):766-775. doi: 10.1016/j.csda.2008.06.007.

Enfuvirtide (ENF) is a fusion inhibitor that prevents the entry of HIV virions into target cells. Studying the characteristics of viral evolution during treatment and after a treatment interruption can lend insight into the mechanisms of viral evolution and...

Cite
Kitchen CM, Kroll J, Kuritzkes DR, et al. Two-way Bayesian hierarchical phylogenetic models: An application to the co-evolution of gp120 and gp41 during and after enfuvirtide treatment. Comput Stat Data Anal. 2009;53(3):766-775doi: 10.1016/j.csda.2008.06.007.
Kitchen, C. M., Kroll, J., Kuritzkes, D. R., Bloomquist, E., Deeks, S. G., & Suchard, M. A. (2009). Two-way Bayesian hierarchical phylogenetic models: An application to the co-evolution of gp120 and gp41 during and after enfuvirtide treatment. Computational statistics & data analysis, 53(3), 766-775. https://doi.org/10.1016/j.csda.2008.06.007
Kitchen, Christina M R, et al. "Two-way Bayesian hierarchical phylogenetic models: An application to the co-evolution of gp120 and gp41 during and after enfuvirtide treatment." Computational statistics & data analysis vol. 53,3 (2009): 766-775. doi: https://doi.org/10.1016/j.csda.2008.06.007
Kitchen CM, Kroll J, Kuritzkes DR, Bloomquist E, Deeks SG, Suchard MA. Two-way Bayesian hierarchical phylogenetic models: An application to the co-evolution of gp120 and gp41 during and after enfuvirtide treatment. Comput Stat Data Anal. 2009 Jan 15;53(3):766-775. doi: 10.1016/j.csda.2008.06.007. PMID: 20442796; PMCID: PMC2862497.
Copy Download .nbib Format: NLM
Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation.

Journal of the American Heart Association

Hsue PY, Scherzer R, Hunt PW, Schnell A, Bolger AF, Kalapus SC, Maka K, Martin JN, Ganz P, Deeks SG.
PMID: 23130122
J Am Heart Assoc. 2012 Apr;1(2). doi: 10.1161/JAHA.111.000422. Epub 2012 Apr 24.

BACKGROUND: Shear stress gradients and inflammation have been causally associated with atherosclerosis development in carotid bifurcation regions. The mechanism underlying higher levels of carotid intima-media thickness observed among HIV-infected individuals remains unknown.METHODS AND RESULTS: We measured carotid intima-media thickness...

Cite
Hsue PY, Scherzer R, Hunt PW, et al. Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation. J Am Heart Assoc. 2012;1(2)doi: 10.1161/JAHA.111.000422.
Hsue, P. Y., Scherzer, R., Hunt, P. W., Schnell, A., Bolger, A. F., Kalapus, S. C., Maka, K., Martin, J. N., Ganz, P., & Deeks, S. G. (2012). Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation. Journal of the American Heart Association, 1(2), . https://doi.org/10.1161/JAHA.111.000422
Hsue, Priscilla Y, et al. "Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation." Journal of the American Heart Association vol. 1,2 (2012). doi: https://doi.org/10.1161/JAHA.111.000422
Hsue PY, Scherzer R, Hunt PW, Schnell A, Bolger AF, Kalapus SC, Maka K, Martin JN, Ganz P, Deeks SG. Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation. J Am Heart Assoc. 2012 Apr;1(2). doi: 10.1161/JAHA.111.000422. Epub 2012 Apr 24. PMID: 23130122; PMCID: PMC3487373.
Copy Download .nbib Format: NLM
Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule.

Canada communicable disease report = Releve des maladies transmissibles au Canada

Tunis MC, Deeks SL.
PMID: 29770021
Can Commun Dis Rep. 2016 Jul 07;42(7):149-151. doi: 10.14745/ccdr.v42i07a03. eCollection 2016 Jul 07.

BACKGROUND: Human papillomavirus (HPV) infections are the most common sexually transmitted infections, and in the absence of vaccination it is estimated that 75 percent of sexually active Canadians will have an HPV infection at some point in their lives....

Cite
Tunis MC, Deeks SL. Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule. Can Commun Dis Rep. 2016;42(7):149-151doi: 10.14745/ccdr.v42i07a03.
Tunis, M. C., Deeks, S. L. (2016). Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule. Canada communicable disease report = Releve des maladies transmissibles au Canada, 42(7), 149-151. https://doi.org/10.14745/ccdr.v42i07a03
Tunis, M C, et al. "Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule." Canada communicable disease report = Releve des maladies transmissibles au Canada vol. 42,7 (2016): 149-151. doi: https://doi.org/10.14745/ccdr.v42i07a03
Tunis MC, Deeks SL. Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule. Can Commun Dis Rep. 2016 Jul 07;42(7):149-151. doi: 10.14745/ccdr.v42i07a03. eCollection 2016 Jul 07. PMID: 29770021; PMCID: PMC5757707.
Copy Download .nbib Format: NLM
Assessing vaccine safety within Ontario's Universal Influenza Immunization Program, 2012-2013 to 2014-2015.

Canada communicable disease report = Releve des maladies transmissibles au Canada

Harris T, Wong K, Nair J, Fediurek J, Deeks SL.
PMID: 29770028
Can Commun Dis Rep. 2016 Sep 01;42(9):181-186. doi: 10.14745/ccdr.v42i09a04. eCollection 2016 Sep 01.

BACKGROUND: Influenza vaccine is recommended to prevent influenza-related morbidity and mortality. Post-marketing surveillance of adverse events following influenza vaccine is essential to monitor vaccine safety, inform immunization program planning and evaluation, and build confidence in immunization.OBJECTIVE: To summarize adverse...

Cite
Harris T, Wong K, Nair J, et al. Assessing vaccine safety within Ontario's Universal Influenza Immunization Program, 2012-2013 to 2014-2015. Can Commun Dis Rep. 2016;42(9):181-186doi: 10.14745/ccdr.v42i09a04.
Harris, T., Wong, K., Nair, J., Fediurek, J., & Deeks, S. L. (2016). Assessing vaccine safety within Ontario's Universal Influenza Immunization Program, 2012-2013 to 2014-2015. Canada communicable disease report = Releve des maladies transmissibles au Canada, 42(9), 181-186. https://doi.org/10.14745/ccdr.v42i09a04
Harris, T, et al. "Assessing vaccine safety within Ontario's Universal Influenza Immunization Program, 2012-2013 to 2014-2015." Canada communicable disease report = Releve des maladies transmissibles au Canada vol. 42,9 (2016): 181-186. doi: https://doi.org/10.14745/ccdr.v42i09a04
Harris T, Wong K, Nair J, Fediurek J, Deeks SL. Assessing vaccine safety within Ontario's Universal Influenza Immunization Program, 2012-2013 to 2014-2015. Can Commun Dis Rep. 2016 Sep 01;42(9):181-186. doi: 10.14745/ccdr.v42i09a04. eCollection 2016 Sep 01. PMID: 29770028; PMCID: PMC5757718.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 276 entries